Wed. 15 May 2024, 7:12am ET
Benzinga
Earnings, Earnings Misses, News
Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.24) by 16.67 percent. This is a 12 percent decrease over losses of $(0.25) per share from the same period last year.